Role of Tumor Necrosis Factor Receptor 1 in Sex Differences of Stem Cell Mediated Cardioprotection
|
|
- Gyles Taylor
- 5 years ago
- Views:
Transcription
1 ADULT CARDIAC Role of Tumor Necrosis Factor Receptor 1 in Sex Differences of Stem Cell Mediated Cardioprotection Courtney N. Zeller,* Yue Wang, PhD,* Troy A. Markel, MD, Brent Weil, MD, Aaron Abarbanell, MD, Jeremy L. Herrmann, MD, Megan L. Kelly, MS, Arthur Coffey, MD, and Daniel R. Meldrum, MD Clarian Cardiovascular Surgery, Departments of Surgery, and Cellular and Integrative Physiology, and Center for Immunobiology, Indiana University School of Medicine, Indianapolis, Indiana Background. Mesenchymal stem cells (MSCs) hold great therapeutic potential for the repair and regeneration of ischemic tissue, possibly through the release of beneficial paracrine factors. Sex differences have been observed in the paracrine function of MSCs. Female stem cells produce lower proinflammatory cytokines and higher levels of growth factors compared with their male counterparts. Ablation of tumor necrosis factor receptor 1 (TNFR1) increases protective growth factor production by male, but not by female, MSCs. We therefore hypothesized the following: (1) that female MSCs would improve myocardial recovery compared with male MSCs after ischemia-reperfusion injury (I/R); and (2) that MSCs isolated from TNFR1 knock out male, but not female, mice, would improve postischemic myocardial recovery compared with their wild type (WT) counterparts. Methods. Male adult Sprague-Dawley rat hearts were subjected to I/R by Langendorff isolated heart preparation. The MSCs were harvested from adult mice and cultured under normal conditions. Immediately prior to ischemia, one million MSCs were infused into the coronary circulation. Cardiac functional parameters were recorded continuously. Results. Pretreatment with MSCs from either sex significantly increased postischemic myocardial recovery as evidenced by improved left ventricular developed pressure, contractility, and rate of relaxation. Infusion with female MSCs was associated with a greater degree of myocardial recovery after I/R compared with male MSCs. The TNFR1 deficiency increased the degree of myocardial recovery associated with male MSCs, but not with female MSCs. No additional cardioprotection was observed when TNFR1 was ablated in female MSCs. Conclusion. Sex differences influence the cardioprotective effects of both WT and TNFR1 ablated MSCs. (Ann Thorac Surg 2009;87:812 9) 2009 by The Society of Thoracic Surgeons Accepted for publication Dec 5, *Drs Zeller and Wang contributed equally to this work. Address correspondence to Dr Meldrum, 635 Barnhill Drive, Van Nuys Medical Science Bldg., Rm. # 2017, Indianapolis, Indiana 46202; dmeldrum@iupui.edu. Myocardial ischemia remains a leading cause of morbidity and mortality worldwide [1, 2]. Ischemia-mediated myocardial injury can be worsened after restoration of coronary flow (reperfusion). Oxygen radicals generated at the time of reperfusion cause further cellular death as well as microvascular and endothelial injury [3]. Mesenchymal stem cells (MSCs) represent a novel treatment modality for myocardial ischemia and reperfusion (I/R) injury [4]. Although the mechanisms behind stem-cell-mediated cardioprotection remain poorly understood, stem cells appear to mediate their beneficial effects in part by producing cytoprotective paracrine factors. These cytoprotective factors have been shown to reduce inflammation, decrease apoptotic cell death, and improve overall myocardial function [5 9]. Tumor necrosis factor alpha (TNF- ) is a proinflammatory cytokine that is produced by a variety of cell types. An elevated level of TNF- is typically noted after myocardial I/R injury [10]. The effects of TNF- are mediated by TNF receptor 1 (TNFR1) and TNF receptor 2 (TNFR2) [10]. The activation of TNFR1 has been reported to suppress neural progenitor proliferation [11], decrease MSC growth factor production [12], generate reactive oxygen species (ROS), and induce apoptosis [13]. In contrast, TNFR2 does not contain a death domain and cannot transmit apoptotic signals [13]. The activation of TNFR2 leads to persistent, PI3K-dependent nuclear factor- B activation, which could be essential for cell survival, proliferation, and growth factor production [14 16]. Sex differences exist in the paracrine actions of MSCs. As we reported previously, female MSCs produce more beneficial growth factors (more vascular endothelial growth factors [VEGF]), less proinflammatory cytokines (TNF and interleukin [IL]-6), and undergo less apoptotic death in response to hypoxia and lipopolysaccharides (LPS) than their male counterparts [17 19]. Interestingly, TNFR1 deficiency increased VEGF production, decreased IL-6 and TNF production in male MSCs, but not in female MSCs after exposure to hypoxia and LPS [19].Itis unknown whether sex differences in TNFR1-deficient MSCs affect cardioprotection during myocardial I/R. We 2009 by The Society of Thoracic Surgeons /09/$36.00 Published by Elsevier Inc doi: /j.athoracsur
2 Ann Thorac Surg ZELLER ET AL 2009;87:812 9 TNFR1 DEFICIENCY IMPROVES MALE MSC CARDIOPROTECTION hypothesized the following: (1) that female MSCs would improve myocardial recovery to a greater degree compared with male MSCs after I/R; and (2) that MSCs isolated from TNFR1 deficient male, but not female, mice would improve postischemic myocardial recovery compared with their wild type (WT) counterparts. Material and Methods Animals Normal adult male Sprague-Dawley rats were obtained from Harlan (200 to 250 g; Indianapolis, IN). Wild type C57BL/6J mice and TNFR1-deficient mice (6 to 8 weeks old) on a background of C57BL/6J were obtained from Jackson Laboratory (Bar Harbor, ME). Mice that are homozygous for TNFR1 allele are viable, normal in size, and do not display any gross physical abnormalities. Animals were fed a standard diet and acclimated in a quiet quarantine room for 1 week before the experiments. The 813 animal protocol was reviewed and approved by the Indiana Animal Care and Use Committee of Indiana University. All animals received humane care in compliance with the Guide for the Care and Use of Laboratory Animals (NIH publication No , revised 1985). Preparation of Mouse Bone Marrow Stromal Cells A single-step stem cell purification method using adhesion to cell culture plastic was employed as previously described [20]. Briefly, adult mouse bone marrow stem cells were collected from bilateral femurs and tibias after sacrifice by removing the epiphyses and flushing the shaft with complete media (Iscove s Modified Dulbecco s Medium; Invitrogen, Carlsbad, CA) and 10% fetal bovine serum (GIBCO Invitrogen, Carlsbad, CA), using a syringe with a 26G needle. Cells were disaggregated by vigorous pipetting several times, and were passed through a 30- m nylon mesh to remove remaining clumps of tissue. Cells were washed by adding complete media, centrifuging ADULT CARDIAC Fig 1. Intracoronary infusion of female MSCs provided greater cardioprotection compared with male MSCs. Although MSCs of either sex improved cardiac function after ischemic injury, hearts infused with FWT MSCs had greater functional recovery. This was seen in higher LVDP, dp/dt, dp/dt, and lower EDP during reperfusion (A, E, G) and at the end of reperfusion (D, F). No significant differences were noted when comparing EDP among all groups (C). (A, B, E H): data were expressed as % of equilibration. (* p 0.05 MWT vs vehicle control; p 0.05 FWT vs vehicle control; # p 0.05 FWT vs MWT as determined using two-way analysis of variance with repeated measures followed by a Bonferroni post hoc analysis (n 5). (EDP end diastolic pressure; FWT female wild type; LVDP left ventricular developed pressure; MSCs mesenchymal stem cells; MWT male wild type; vehicle control; Œ MWT; FWT.)
3 ADULT CARDIAC 814 ZELLER ET AL Ann Thorac Surg TNFR1 DEFICIENCY IMPROVES MALE MSC CARDIOPROTECTION 2009;87:812 9 for 5 minutes at 300 g at 24 C, and removing the supernatant. The cell pellet was then resuspended and cultured in 75 cm 2 culture flasks with complete media at 37 C in 5% CO 2 in air. The MSCs preferentially attached to the polystyrene surface; after 48 hours, nonadherent cells in suspension were discarded. Fresh complete media was added and replaced every 3 or 4 days thereafter. When the cultures reached 90% of confluence, the stem cell culture was passaged; cells were recovered by the addition of a solution 0.25% trypsin-ethylenediaminetetraacetic acid (GIBCO Invitrogen, Carlsbad, CA) and replated in flasks. The MSCs were negative for the hematopoietic markers CD34 ( 95%) and CD45 ( 94%), and were positive for the mesenchymal stem cell marker CD44 ( 96%) [21]. Cells were utilized for experimentation between passages 3 and 7. Isolated Heart Preparation (Langendorff) Rats were anesthetized (sodium pentobarbital, 60 mg/kg intraperitoneal [i.p.]) and heparinized (500 U i.p.), and hearts were rapidly excised by median sternotomy and placed in 4 C Krebs-Henseleit solution (119 mm sodium chloride, 20.8 mm sodium bicarbonate, 11 mm dextrose, 12 mm calcium chloride dihydrate, 47 mm potassium chloride, 11.7 mm magnesium sulfate heptahydrate, and 11.8 mm potassium dihydrogen phosphate). The aorta was cannulated and the heart was perfused under constant pressure (mean 75 mm Hg) with oxygenated (95% O 2 /5% CO 2 ) Krebs-Henseleit solution (37 C). A left atrial resection was performed prior to insertion of a waterfilled latex balloon through the atrium into the ventricle. The balloon was initially adjusted to a desired mean end diastolic pressure (EDP) of 5 mm Hg and hearts were allowed to equilibrate for 15 minutes. Pacing wires were fixed to the atrium and hearts were paced at approximately 6 Hz, 3V, 2 ms (350 beats per minute) during equilibration and reperfusion to ensure a standard heart rate between groups. A three-way stopcock above the aortic root was used to create warm global ischemia, during which the heart was placed in a 37 C degassed Fig 2. Stem cells isolated from TNFR1 deficient male mice demonstrated greater degree of cardioprotection compared with their WT counterparts. Hearts infused with male TNFR1 knockout MSCs (MR1KO) demonstrated greater level of functional recovery compared with those infused with MWT MSCs (MR1KO). This was noted by higher LVDP, dp/dt, dp/dt, and lower EDP during reperfusion (A, C, E, G) and at the end of reperfusion (B, F, H). A statistically significant trend was observed when comparing the groups at the end of reperfusion (p 0.1, D). (A, B, E H): data were expressed as % of equilibration. (* p 0.05 MWT vs MR1KO as determined using two-way analysis of variance with repeated measures followed by a Bonferroni post hoc analysis [n 5]; EDP end diastolic pressure; LVDP left ventricular developed pressure; MR1KO male TNFR1KO; MSCs mesenchymal stem cells; MWT male wild type; TNFR1 tumor necrosis factor receptor 1; MFWT; Œ MR1KO.)
4 Ann Thorac Surg ZELLER ET AL 2009;87:812 9 TNFR1 DEFICIENCY IMPROVES MALE MSC CARDIOPROTECTION organ bath. After 25 minutes of ischemia, hearts were reperfused for 60 minutes. The left ventricular developed pressure (LVDP), EDP, rate of contraction (delta pressure/delta time [ dp/dt]), and rate of relaxation ( dp/dt) were continuously recorded using a PowerLab 8 preamplifier/digitizer (AD Instruments Inc., Milford, MA) and an Apple G4 PowerPC computer (Apple Computer Inc., Cupertino, CA). Experimental Isolated Heart Groups Rat hearts were divided into the following groups (n 5 per group): (1) control; (2) male wild type (MWT) MSC infusion; (3) female wild type (FWT) MSC infusion; (4) male TNFR1KO (MR1KO) MSC infusion; and (5) female TNFR1KO (FR1KO) MSC infusion. The MSCs were treated with trypsin. Single-cell suspension was mixed with an equal volume of trypan blue (20 l, 0.4%; Lonza, Walkersville, MD) to mark dead cells. The mixture was 815 allowed to sit at room temperature for a few minutes (less than 10 minutes). Viable cells exclude trypan blue, while dead cells stain blue due to trypan blue uptake. Cells were loaded onto a cytometer and then counted by microscopy. One million viable cells were isolated and resuspended in 1 ml of Krebs-Henseleit solution (37 C). Over the course of one minute prior to ischemia, the solution containing 1 million MSCs was infused into the coronary circulation (infusion rate: 1 million cells/1 minute/1 ml of Krebs-Henseleit solution). Presentation of Data and Statistical Analysis All reported values are mean standard error of the mean and a p value less than 0.05 was considered statistically significant. Left ventricular developed pressure (LVDP), rate of contraction ( dp/dt), and rate of relaxation ( dp/dt) are presented as a percentage of baseline during equilibration. Data were compared using ADULT CARDIAC Fig 3. No significant difference was observed in stem cell mediated cardioprotection between MSCs isolated from female TNFR1 deficient mice and their wild type counterparts. The MSCs isolated from TNFR1 knockout female mice did not demonstrate a greater level of cardioprotection compared with FWT MSCs after ischemia-reperfusion injury. No significant difference was observed in LVDP and EDP during reperfusion and at end reperfusion (A, B, C, D). Although dp/dt and dp/dt were significantly faster at 30 minutes after reperfusion (E, G), there is no difference in dp/dt and dp/dt at end reperfusion (F, H). (A, B, E H): data were expressed as % of equilibration. (EDP end diastolic pressure; FR1KO female TNFR1KO; FWT female wild type; LVDP left ventricular developed pressure; MSCs mesenchymal stem cells; TNFR1 tumor necrosis factor receptor 1; * p 0.05 FWT vs FR1KO as determined using two-way analysis of variance with repeated measures followed by a Bonferroni post hoc analysis [n 5]; FWT; Œ FR1KO.)
5 ADULT CARDIAC 816 ZELLER ET AL Ann Thorac Surg TNFR1 DEFICIENCY IMPROVES MALE MSC CARDIOPROTECTION 2009;87:812 9 two-way analysis of variance (ANOVA) with repeated measures (RANOVA) with post hoc Bonferroni. Results Stem cells Improve Myocardial Functional Recovery After Ischemic Injury Treatment of hearts with MSCs of either sex prior to ischemia resulted in significantly improved postischemic functional recovery as compared with vehicle controls. This was demonstrated, specifically, through improved LVDP, dp/dt, and dp/dt in the experimental groups as compared with controls (Figs 1A; 1B; 1E; 1F; 1G). For example, at end reperfusion LVDP was significantly higher in both the male MSC and female MSC groups compared with vehicle control ( %, %, and % of baseline for the male MSC group, female MSC group, and vehicle control group, respectively; Fig 1B). Compared with male MSCs, female MSCs conferred a greater degree of myocardial protection after I/R. The hearts infused with female MSCs had significantly higher LVDP compared with those infused with male MSCs after I/R (Figs 1A and 1B). Knockout of TNFR1 Improves Male MSC-Mediated Cardioprotection Male wild type and TNFR1 knockout (MR1KO) MSCs were used to investigate the role of TNFR1 in MSCmediated cardioprotection. Hearts infused with MR1KO MSCs had significantly higher LVDP, dp/dt, dp/dt, and lower EDP after I/R compared with the MWT group (Figs 2A 2H). Knockout of TNFR1 Has Little Effect on Female MSC-Mediated Cardioprotection In contrast to male MSCs, knockout TNFR1 had little effect on female MSC-mediated cardioprotection. Although hearts infused with female TNFR1 knockout (FR1KO) MSCs had significantly higher dp/dt and Fig 4. Intracoronary infusion of male MSCs isolated from TNFR1 deficient mice provided greater cardioprotection compared with FWT MSCs. The heart infused with male TNFR1 ablated MSCs (MR1KO) demonstrated higher LVDP, dp/dt, dp/dt, and lower EDP during reperfusion (A, C, E, G) and at the end of reperfusion (F). No significant differences were noted when comparing EDP at the end of reperfusion (D). (A, B, E H): data were expressed as % of equilibration. (EDP end diastolic pressure; MR1KO male TNFR1KO; FWT female wild type; LVDP left ventricular developed pressure; MSCs mesenchymal stem cells; TNFR1 tumor necrosis factor receptor 1; * p 0.05 FWT vs MR1KO as determined using twoway analysis of variance with repeated measures followed by a Bonferroni post hoc analysis [n 5]; FWT; Œ MR1KO.)
6 Ann Thorac Surg ZELLER ET AL 2009;87:812 9 TNFR1 DEFICIENCY IMPROVES MALE MSC CARDIOPROTECTION dp/dt at 30 minutes after reperfusion, no significant difference was observed between the groups infused with FWT or FR1KO MSCs at the end of reperfusion (Fig 3). Male TNFR1 Knockout MSCs Exert a Greater Degree of Cardioprotection Compared With Female Wild Type MSCs Knockout of TNFR1 significantly increased the cardioprotection of male MSCs. Interestingly, MR1KO MSCs conferred a greater level of myocardial protection compared with female WT MSCs. Hearts infused with MR1KO MSCs demonstrated significantly higher LVDP, dp/dt, dp/dt, and lower EDP compared with FWT MSCs-treated groups after I/R (Fig 4). Comment Mesenchymal stem cells hold great therapeutic potential for the repair and regeneration of ischemic tissue [22]. Herein, we demonstrate the following: (1) that adult MSC infusion increases postischemic myocardial functional recovery; (2) that female MSCs confer a greater level of cardioprotection compared with male MSCs; and (3) that TNFR1 deficiency significantly increases male MSCmediated cardioprotection, but have little effect on the protective effects of female MSCs. More than a decade of research in experimental models indicates that delivery of stem cells into ischemic myocardium positively remodels and regenerates injured tissue, improves cardiac function, and protects tissue from further insult [4]. Stem cells may exert their beneficial effects by several different mechanisms. Some studies suggest that stem cells differentiate into specific end organ cells, which then become incorporated into the tissue to increase postinjury functional recovery [23]. However, other evidence indicates that stem cells may mediate their beneficial effects by the release of cytoprotective paracrine factors that promote tissue repair and improvement in organ function [9, 24]. Evidence to support the paracrine actions of stem cells has been demonstrated from several studies. First, donor stem cell engraftment and survival after transplantation has been shown from previous studies to be only 1% to 5%, which is likely too few cells to be relevant therapeutically and to directly influence organ function [25]. Second, we and others have demonstrated that stem cell-mediated improvement in end organ function occurs within 72 hours of injury, precluding differentiation as a cause due to time required for meaningful differentiation and regeneration of these donor cells [4]. Third, in vitro and in vivo animal studies have revealed that much of the functional improvement and attenuation of injury afforded by stem cells can be replicated by the cell-free, conditioned media that derived from stem cells in culture [7, 26]. In this study, acute application of MSCs into injured cardiac tissue attenuated I/R injury and these protective effects occur less than 1 hour after injury, thus precluding a cardioprotective benefit due to any meaningful rate of donor cell myogenic differentiation and regeneration. Indeed, we have previously shown that myocardium 817 infused with female MSCs exhibited decreased TNF- and increased VEGF compared with hearts infused with male MSCs [17]. Taken together, these observations indicate that stem cells mediate their protection by releasing cytoprotective paracrine factors and decreasing proinflammatory cytokines in myocardium. The beneficial growth factors could improve heart function by the following: (1) binding to their receptors localized on cardiomyocytes (in vitro isolated heart preparation); (2) suppressing proinflammatory cytokines (in vitro and in vivo myocardial infarction models); and (3) facilitating angiogenesis (in vivo models of myocardial infarction). Sex differences exist in stem cell paracrine growth factor production. Interestingly, there is an apparent sex difference in cardiovascular diseases. Men appear to have more rapid progression of heart failure, less preservation of myocardial mass as they age, and worse age-matched cardiac contractility compared with women [27]. Conversely, females have a lower incidence of heart failure, a higher rate of survival [28], and a cardioprotective advantage after I/R injury [29]. It is unknown whether differences in cardiovascular diseases between males and females may be due in part to the differences in endogenous stem cell function and repair. Production of TNF- by cardiomyocytes and resident macrophages is significantly upregulated after I/R injury [10]. We reported previously [30] that TNF- stimulates MSCs to release beneficial growth factors. However, TNF- can also induce apoptosis [13], suppress proliferation of neural progenitor cells [11] and decrease the secretion of VEGF and insulin-like growth factor 1 (IGF-1) by mouse MSCs [12]. This led to the important appreciation that TNF- itself may have both beneficial and detrimental effects on stem cell-mediated protection depending on which of its receptors (TNFR1 or TNFR2) is activated. The TNFR1 correlates with decreased progenitor cell proliferation [31], generation of ROS as well as capable of inducing apoptosis [11]; in contrast, TNFR2 could be essential for cell survival, proliferation, and growth factor production [14 16]. Indeed, TNFR1 deficiency increased VEGF production and decreased IL-6 and TNF production in male MSCs, but not in female MSCs [19]. These observations, together with data presented in this manuscript, demonstrate that TNFR1 signaling attenuates MSC-mediated protection and beneficial growth factor production in males, but not in females. The higher level of beneficial growth factors, lower level of proinflammatory cytokines produced by female MSCs, and their relatively higher resistance to insult may be attributable to differential intracellular TNF signaling [32]. The estrogen-upregulated, suppressor-of-cytokine-signaling-3 and signal transducer and activator of transcription 3, could underlie the relative TNFR1 resistance in female MSCs as demonstrated by previous work in our lab [32, 33]. Further studies to examine this mechanism, however, are warranted. In conclusion, we demonstrate that sex differences influence the cardioprotective effects of MSCs. The ablation of TNFR1 significantly increases male MSCmediated cardioprotection, but had no effect on the ADULT CARDIAC
7 ADULT CARDIAC 818 ZELLER ET AL Ann Thorac Surg TNFR1 DEFICIENCY IMPROVES MALE MSC CARDIOPROTECTION 2009;87:812 9 cardioprotective effects of female stem cells. Understanding how stem cells protect ischemic myocardium is important for optimizing the cytoprotective effects of these cells and may result in pharmacologically or genetically modified cells that provide maximum protection to injured tissue. Additional in vivo studies must be implemented to address the long-term efficacy and potential tumorigenicity of implanted stem cells prior to widespread human application. This work was supported in part by National Institutes of Health grants NIH R01GM070628, NIH R01HL085595, NIH K99/R00 HL , and NIH F32 HL085982, an American Heart Association (AHA) Grant in aid, and AHA Postdoctoral Fellowship Z. References 1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause : Global Burden of Disease Study. Lancet 1997;349: Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008;117:e Yellon DM, Baxter GF. Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? Heart 2000;83: Wang M, Tsai BM, Crisostomo PR, Meldrum DR. Pretreatment with adult progenitor cells improves recovery and decreases native myocardial proinflammatory signaling after ischemia. Shock 2006;25: Haider HKh, Ashraf M. Bone marrow stem cell transplantation for cardiac repair. Am J Physiol Heart Circ Physiol 2005; 88:H Kudo M, Wang Y, Wani MA, Xu M, Ayub A, Ashraf M. Implantation of bone marrow stem cells reduces the infarction and fibrosis in ischemic mouse heart. J Mol Cell Cardiol 2003;35: Gnecchi M, He H, Liang OD, et al. Paracrine action accounts for marked protection of ischemic heart by Akt-modified mesenchymal stem cells. Nat Med 2005;11: Tögel F, Hu Z, Weiss K, Isaac J, Lange C, Westenfelder C. Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiationindependent mechanisms. Am J Physiol Renal Physiol 2005;289:F Gnecchi M, He H, Noiseux N, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. Faseb J 2006;20: Meldrum DR. Tumor necrosis factor in the heart. Am J Physiol 1998;274(3 pt 2):R Iosif RE, Ekdahl CT, Ahlenius H. Tumor necrosis factor receptor 1 is a negative regulator of progenitor proliferation in adult hippocampal neurogenesis. J Neurosci 2006;26: Markel TA, Crisostomo PR, Wang M, Herring CM, Meldrum DR. Activation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production. Am J Physiol Gastrointest Liver Physiol 2007; 293:G Schütze S, Tchikov V, Schneider-Brachert W. Regulation of TNFR1 and CD95 signalling by receptor compartmentalization. Nat Rev Mol Cell Biol 2008;9: Marchetti L, Klein M, Schlett K, Pfizenmaier K, Eisel UL. TNF mediated neuroprotection against glutamate induced excitotoxicity is enhanced by NMDA receptor activation: essential role of a TNF receptor 2 mediated, PI3 kinase dependent NF-kB pathway. J Biol Chem 2004;279: Crisostomo PR, Wang Y, Markel TA, Wang M, Lahm T, Meldrum DR. Human mesenchymal stem cells stimulated by TNF-alpha, LPS, or hypoxia produce growth factors by an NF kappa B- but not JNK-dependent mechanism. Am J Physiol Cell Physiol 2008;294:C Ait-Ali D, Turquier V, Tanguy Y, et al. Tumor necrosis factor (TNF)-alpha persistently activates nuclear factorkappab signaling through the type 2 TNF receptor in chromaffin cells: implications for long-term regulation of neuropeptide gene expression in inflammation. Endocrinology 2008;149: Crisostomo PR, Markel TA, Wang M, Lahm T, Lillemoe KD, Meldrum DR. In the adult mesenchymal stem cell population, source gender is a biologically relevant aspect of protective power. Surgery 2007;142: Crisostomo PR, Wang M, Herring CM, et al. Sex dimorphisms in activated mesenchymal stem cell function. Shock 2006;26: Crisostomo PR, Wang M, Herring CM, et al. Gender differences in injury induced mesenchymal stem cell apoptosis and VEGF, TNF, IL-6 expression: role of the 55 kda TNF receptor (TNFR1). J Mol Cell Cardiol 2007;42: Peister A, Mellad JA, Larson BL, Hall BM, Gibson LF, Prockop DJ. Adult stem cells from bone marrow (MSCs) isolated from different strains of inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103: Markel TA, Wang M, Crisostomo PR, Manukyan MC, Poynter JA, Meldrum DR. Neonatal stem cells exhibit specific characteristics in function, proliferation, and cellular signaling that distinguish them from their adult counterparts. Am J Physiol Regul Integr Comp Physiol 2008;294:R Springer ML, Brazelton TR, Blau HM. Not the usual suspects: the unexpected sources of tissue regeneration. J Clin Invest 2001;107: Li Z, Wu JC, Sheikh AY, Kraft D, et al. Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease. Circulation 2007;116:I Scherschel JA, Soonpaa MH, Srour EF, Field LJ, Rubart M. Adult bone marrow-derived cells do not acquire functional attributes of cardiomyocytes when transplanted into periinfarct myocardium. Mol Ther 2008;16: Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res 2006;98: Guo Y, Graham-Evans B, Broxmeyer HE. Murine embryonic stem cells secrete cytokines/growth modulators that enhance cell survival/anti-apoptosis and stimulate colony formation of murine hematopoietic progenitor cells. Stem Cells 2006;24: Morris MC, Ittenbach RF, Godinez RI, et al. Risk factors for mortality in 137 pediatric cardiac intensive care unit patients managed with extracorporeal membrane oxygenation. Crit Care Med 2004;32: Tunstall-Pedoe H, Morrison C, Woodward M, Fitzpatrick B, Watt G. Sex differences in myocardial infarction and coronary deaths in the Scottish MONICA population of Glasgow 1985 to Presentation, diagnosis, treatment, and 28-day case fatality of 3991 events in men and 1551 events in women. Circulation 1996;93: Yu HP, Shimizu T, Choudhry MA, et al. Mechanism of cardioprotection following trauma-hemorrhagic shock by a selective estrogen receptor-beta agonist: up-regulation of cardiac heat shock factor-1 and heat shock proteins. J Mol Cell Cardiol 2006;40: Wang Y, Crisostomo PR, Wang M, Markel TA, Novotny NM, Meldrum DR. TGF-alpha increases human mesenchymal stem cell-secreted VEGF by MEK and PI-3 K, but not JNK or
8 Ann Thorac Surg ZELLER ET AL 2009;87:812 9 TNFR1 DEFICIENCY IMPROVES MALE MSC CARDIOPROTECTION ERK, dependent mechanisms. Am J Physiol Regul Integr Comp Physiol 2008;295:R Zhang Y, Harada A, Bluethmann H, et al. Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor p55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF alpha in vitro. Blood 1995;86: Wang M, Markel T, Crisostomo P, et al. Deficiency of TNFR1 protects myocardium through SOCS3 and IL-6 but not p38 MAPK or IL-1beta. Am J Physiol Heart Circ Physiol 2007;292: H Wang M, Crisostomo PR, Markel TA, Wang Y, Meldrum DR. Mechanisms of sex differences in TNFR2-mediated cardioprotection. Circulation 2008;118:S ADULT CARDIAC INVITED COMMENTARY In the last 5 years, significant enthusiasm (both experimentally and clinically) exists to apply progenitor cells to modify the myocardial response to injury. In many ways, the popular appeal of stem cell therapy, as well as its vast potential, has led to the quick adoption of these approaches into human clinical trials. Meanwhile, much remains to be learned about individual cell types and their mechanism of action. In the article by Zeller and colleagues [1], the group from Indiana continues their investigation of the effects of mesenchymal stem cells (MSCs) to provide myocardial protection from ischemiareperfusion. When delivered through the coronary circulation, we know that few MSCs actually can be identified in the heart. As with other groups, this group believes that many of the positive effects of MSCs are related to their paracrine effects. This group has a long history of studying cytokine biology, and the gender effect of cytokines and myocardial injury in particular. They have previously demonstrated that MSCs from female donors produce less pro-inflammatory cytokines and more growth factors than their male counterparts. They have shown further that this observation may be related to activation of the tumor necrosis factor receptor 1 (TNFR1), whereby male mice deficient in this receptor manifest a more favorable cytokine profile, and females are unaffected by TNFR1 ablation. In the current report, the authors extend their observations of MSCs in culture (hypoxia and lipopolysaccharide) to a standard ex-vivo Langendorff preparation. They demonstrate that MSCs from either gender, but moreso with female MSCs, appropriately improve post-ischemic functional recovery. The MSCs from male TNFR1- deficient animals improved cardioprotection, whereas those from females were no different than their wild-type mates. This effect from the male knock-out cells was even more pronounced than the baseline protection afforded by the wild-type female MSCs. The implied implications potentially relevant to human use of this form of therapy are: (1) female donor MSCs might be a preferred source of cells, especially because one of the advantages of MSCs in their relative immune tolerance, and (2) manipulation of the TNFR1 receptor in male donor cells might provide even a better source of MSCs. Of course, the appeal of the current study is not so much in its direct clinical relevance, but in its continued search for understanding how these cells actually work. Although the authors use transgenic animals to hint of mechanism, this report is only observational and leaves the reader wondering why TNFR1 ablation in females MSCs makes no difference, whereas it dramatically increases cardioprotection induced by male MSCs. Because this is a functional Langendorff study, many questions remain related to cellular infiltration, cytokine and growth factor production, and cell viability. Admittedly, the authors acknowledge several potential targets for further mechanistic study, which we will be interested in seeing as this line of investigation evolves. Craig Selzman, MD Division of Cardiothoracic Surgery University of Utah 30 N 1900 E, 3C 127 SOM Salt Lake City, UT craig.selzman@hsc.utah.edu Reference 1. Zeller CN, Wang Y, Markel TA. Role of tumor necrosis factor receptor 1 in sex differences of stem cell mediated cardioprotection. Ann Thorac Surg 2009;87: by The Society of Thoracic Surgeons /09/$36.00 Published by Elsevier Inc doi: /j.athoracsur
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy
Paracrine Mechanisms in Adult Stem Cell Signaling and Therapy Massimiliano Gnecchi, Zhiping Zhang, Aiguo Ni, Victor J. Dzau Circulation Research 2008 Nov 21;103(11):1204-19 Introduction(1) After AMI all
More informationE. Cervio, P. Danieli, C. Ciuffreda, F. Pisano, M. Roccio, M. Gnecchi. The authors have no financial disclosures to declare
16 th ISCT Annual Meeting SOLUBLE FACTORS RELEASED BY HUMAN MESENCHYMAL STEM CELLS OF FETAL ORIGIN LEAD TO CARDIOMYOCYTE PROTECTION THROUGH THE INHIBITION OF PRO-APOPTOTIC SIGNALING E. Cervio, P. Danieli,
More informationCell therapy: enhancing the therapeutic potential of cardiac progenitors for delivery post myocardial infarction. Rita Alonaizan
Cell therapy: enhancing the therapeutic potential of cardiac progenitors for delivery post myocardial infarction Rita Alonaizan Department of Physiology, Anatomy & Genetics St Catherine s College Supervisor:
More informationSUPPLEMENTAL MATERIAL. Supplementary Methods
SUPPLEMENTAL MATERIAL Supplementary Methods Culture of cardiomyocytes, fibroblasts and cardiac microvascular endothelial cells The isolation and culturing of neonatal rat ventricular cardiomyocytes was
More informationEuropean Society of Cardiology Congress DONOR AGE NEGATIVELY INFLUENCES THE CYTOPROTECTIVE PARACRINE EFFECTS EXERTED BY HUMAN MESENCHYMAL STEM CELLS
European Society of Cardiology Congress 28 Aug - 01 Sep 2009, Stockholm - Sweden DONOR AGE NEGATIVELY INFLUENCES THE CYTOPROTECTIVE PARACRINE EFFECTS EXERTED BY HUMAN MESENCHYMAL STEM CELLS Massimiliano
More informationEstrogen receptor mediates increased activation of PI3K/Akt signaling and improved myocardial function in female hearts following acute ischemia
Am J Physiol Regul Integr Comp Physiol 296: R972 R978, 2009. First published February 11, 2009; doi:10.1152/ajpregu.00045.2009. Estrogen receptor mediates increased activation of PI3K/Akt signaling and
More informationJournal Club Semmler Lorenz
Beer et al. 2015 - Analysis of the Secretome of Apoptotic Peripheral Blood Mononuclear Cells: Impact of Released Proteins and Exosomes for Tissue Regeneration Journal Club 13.11.2017 1 Introduction to
More informationEquivalent Cardioprotection Induced by Ischemic and Hypoxic Preconditioning
Original Cardiovascular 229 Equivalent Cardioprotection Induced by Ischemic and Hypoxic Preconditioning Xujin Xiang 1 Haixia Lin 2 Jin Liu 1 Zeyan Duan 1 1 Department of Anesthesiology, West China Hospital,
More informationActivation of individual tumor necrosis factor receptors differentially affects stem cell growth factor and cytokine production
Am J Physiol Gastrointest Liver Physiol 293: G657 G662, 2007. First published July 19, 2007; doi:10.1152/ajpgi.00230.2007. Translational Physiology Activation of individual tumor necrosis factor receptors
More informationIn the name of GOD. Animal models of cardiovascular diseases: myocardial infarction & hypertension
In the name of GOD Animal models of cardiovascular diseases: myocardial infarction & hypertension 44 Presentation outline: Cardiovascular diseases Acute myocardial infarction Animal models for myocardial
More informationSupplementary Figure 1. Confocal immunofluorescence showing mitochondrial translocation of Drp1. Cardiomyocytes treated with H 2 O 2 were prestained
Supplementary Figure 1. Confocal immunofluorescence showing mitochondrial translocation of Drp1. Cardiomyocytes treated with H 2 O 2 were prestained with MitoTracker (red), then were immunostained with
More information2. Langendorff Heart
2. Langendorff Heart 2.1. Principle Langendorff heart is one type of isolated perfused heart which is widely used for biochemical, physiological, morphological and pharmacological researches. It provides
More informationc Ischemia (30 min) Reperfusion (8 w) Supplementary Figure bp 300 bp Ischemia (30 min) Reperfusion (4 h) Dox 20 mg/kg i.p.
a Marker Ripk3 +/ 5 bp 3 bp b Ischemia (3 min) Reperfusion (4 h) d 2 mg/kg i.p. 1 w 5 w Sacrifice for IF size A subset for echocardiography and morphological analysis c Ischemia (3 min) Reperfusion (8
More informationMesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future
Mesenchymal Stem Cells to Repair Vascular Damage after Chemotherapy: Past, Present and Future Cell Therapy 2014 Las Vegas, NV, USA Sulaiman Al-Hashmi, PhD Sultan Qaboos University Oman What are MSCs? Stem
More informationDr. Alexander Lyon Senior Lecturer and Consultant Cardiologist Clinical Lead in Cardio-Oncology Royal Brompton Hospital, London UK
Advanced heart failure - devices, mechanical circulatory support and cardiac transplantation Monday 30 January 2017 Stem cell and gene therapies for heart failure Dr. Alexander Lyon Senior Lecturer and
More informationExosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signalling pathway
Exosomes/tricalcium phosphate combination scaffolds can enhance bone regeneration by activating the PI3K/Akt signalling pathway Jieyuan Zhang, Xiaolin Liu, Haiyan Li, Chunyuan Chen, Bin Hu, Xin Niu, Qing
More informationUse of Adipose-Derived Stem Cells in Regenerative Therapy. David Euhus, MD Professor of Surgery UT Southwestern Medical Center at Dallas
Use of Adipose-Derived Stem Cells in Regenerative Therapy David Euhus, MD Professor of Surgery UT Southwestern Medical Center at Dallas Use of Adipose-Derived Stem Cells in Regenerative Therapy David Euhus,
More informationStem Cell Therapy Concept. Pleuripotent Stromal Cells 8/8/2011. Use of Adipose-Derived Stem Cells in Regenerative Therapy
Use of Adipose-Derived Stem Cells in Regenerative Therapy Use of Adipose-Derived Stem Cells in Regenerative Therapy David Euhus, MD Professor of Surgery UT Southwestern Medical Center at Dallas David Euhus,
More informationRegenerative Medicine for Cardiomyocytes
Regenerative Medicine Regenerative Medicine for JMAJ 47(7): 328 332, 2004 Keiichi FUKUDA Assistant Professor, Institute for Advanced Cardiac Therapeutics, Keio University School of Medicine Abstract: Heart
More informationA Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial. Ischemia/Reperfusion Injury
Supporting Information A Long-Term and Slow-Releasing Hydrogen Sulfide Donor Protects against Myocardial Ischemia/Reperfusion Injury Xiaotian Sun 1 *, Wenshuo Wang 2, Jing Dai 3, Sheng Jin 4, Jiechun Huang
More informationReperfusion Injury: How Can We Reduce It?
MI/CAD: Practical Question in Management of AMI Patients Reperfusion Injury: How Can We Reduce It? Hyun-Jai Cho, M.D., Ph.D Cardiovascular Center & Department of Internal Medicine Seoul National University
More informationMyocardial infarction
NEW CARDIAC MARKERS AND CARDIAC REGENERATION Päivi Lakkisto, MD, PhD Specialist in Clinical Chemistry Clinical lecturer University of Helsinki and HUSLAB Minerva Institute for Medical Research Myocardial
More informationMultimodality Imaging in Cardiac Stem Cell Research
Multimodality Imaging in Cardiac Stem Cell Research IL SUK SOHN, MD, PhD Department of Cardiology Kyung Hee University Hospital at Gangdong Kyung Hee University School of Medicine, Seoul, Korea Stem Cell
More informationThyroid hormone and cardiac regeneration: from Prometheus myth to reality
Thyroid hormone and cardiac regeneration: from Prometheus myth to reality C. Pantos Unit of Cardiac Regeneration and Cardiopreservation - University of Athens Regeneration : an old concept Amphibian metamorphosis
More informationSolution for cardiac perfusion in viaflex plastic container
CARDIOPLEGIA SOLUTION A Solution for cardiac perfusion in viaflex plastic container DESCRIPTION Cardioplegia Solution A is a sterile, non-pyrogenic solution in a Viaflex bag. It is used to induce cardiac
More informationAmeliorating Reperfusion Injury During Resuscitation from Cardiac Arrest
Ameliorating Reperfusion Injury During Resuscitation from Cardiac Arrest Scott T. Youngquist, MD, MSc Associate Professor, Emergency Medicine University of Utah School of Medicine Medical Director, Salt
More informationB-cell. Astrocyte SCI SCI. T-cell
RF #2015 P-01 PI: Azizul Haque, PhD Grant Title: Targeting Enolase in Spinal Cord Injury 12-month Technical Progress Report Progress Report (First Six Months): Enolase is one of the most abundantly expressed
More informationMolecular Basis of Cardioprotection by Erythropoietin
56 Current Molecular Pharmacology, 2009, 2, 56-69 Molecular Basis of Cardioprotection by Erythropoietin D. Burger 1, A. Xenocostas 2,3 and Q.P. Feng*,1,2,3 1 Department of Physiology and Pharmacology,
More informationSean Davidson. The Hatter Cardiovascular Institute University College London, UK
Key pathways to ischemia-reperfusion injury Sean Davidson The Hatter Cardiovascular Institute University College London, UK Outline What is ischaemia-reperfusion injury? What causes ischaemia-reperfusion
More informationStem Cells. Keith Channon. Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford
Stem Cells Keith Channon Department of Cardiovascular Medicine University of Oxford John Radcliffe Hospital, Oxford Adult Stem Cells Unique cells that are capable of self-renewal Have the ability to differentiate
More informationMesenchymal Stem Cells and Cancer: Their Interplay
Mesenchymal Stem Cells and Cancer: Their Interplay Gang Li, MBBS, DPhil (Oxon) Stem Cell and Regeneration Program School of Biomedical Sciences Li Ka Shing Institute of Health Sciences Department of Orthopaedics
More informationNNZ-2566 in Rett Syndrome and Autism Spectrum Disorders Role and Update
NNZ-2566 in Rett Syndrome and Autism Spectrum Disorders Role and Update 1 Overview The natural growth factor IGF-1 is broken down in the body to IGF-1[1-3] NNZ-2566 is an analogue of IGF-1[1-3] developed
More informationExosomes secreted by Human Cardiac Progenitors contain mirna with cardioprotective and proangiogenic activities
Exosomes secreted by Human Cardiac Progenitors contain mirna with cardioprotective and proangiogenic activities Elisabetta Cervio, PhD Molecular Cardiology Laboratory Cardiocentro Ticino, Lugano, CH International
More informationrenoprotection therapy goals 208, 209
Subject Index Aldosterone, plasminogen activator inhibitor-1 induction 163, 164, 168 Aminopeptidases angiotensin II processing 64 66, 214 diabetic expression 214, 215 Angiotensin I intrarenal compartmentalization
More informationMesenchymal Stem Cells
Mesenchymal Stem Cells Science and therapeutic applications Dirk Büscher (Former VP-R&D Cellerix) GRIFOLS SA May 10 th, 2010 EMA 1 Discovery and Definition of Mesenchymal Stem Cells MSC must be plastic-adherent
More informationDr. Hany M. Abo-Haded
BY Dr. Hany M. Abo-Haded Pediatric Cardiology Unit, Mansoura Universty Children Hospital, Mansoura, Egypt Co-authors: Dina S El-Agamy and Mohamed A Elkablawy Background Doxorubicin (DOX) is an anthracycline
More informationHeart transplantation is the gold standard treatment for
Organ Care System for Heart Procurement and Strategies to Reduce Primary Graft Failure After Heart Transplant Masaki Tsukashita, MD, PhD, and Yoshifumi Naka, MD, PhD Primary graft failure is a rare, but
More informationAdipose Tissue Dysfunction and Diabetic Cardiovascular Disease
Adipose Tissue Dysfunction and Diabetic Cardiovascular Disease Xin-Liang Ma, MD, PhD Thomas Jefferson University Philadelphia, PA USA CVD As The #1 Causes of Death In USA Male Female Heart Disease and
More informationStem Cell Death and Survival in the Regenerating Heart
Stem Cell Death and Survival in the Regenerating Heart Eltyeb Abdelwahid 1, Audrone Kalvelyte 2, Aurimas Stulpinas 2, Luiz Cesar Guarita- Souza 3, Katherine Athayde Teixeira de Carvalho 4, Gabor Foldes
More informationSupplemental Figure 1. Western blot analysis indicated that MIF was detected in the fractions of
Supplemental Figure Legends Supplemental Figure 1. Western blot analysis indicated that was detected in the fractions of plasma membrane and cytosol but not in nuclear fraction isolated from Pkd1 null
More informationResident cardiac stem cells: how to find and use them
Resident cardiac stem cells: how to find and use them G. Hasenfuß Cardiology and Pneumology Heart Research Center Göttingen Georg-August-University Göttingen Definition: Stem cell Selfrenewal Stem cell
More informationProbe. Hind III Q,!?R'!! /0!!!!D1"?R'! vector. Homologous recombination
Supple-Zhang Page 1 Wild-type locus Targeting construct Targeted allele Exon Exon3 Exon Probe P1 P P3 FRT FRT loxp loxp neo vector amh I Homologous recombination neo P1 P P3 FLPe recombination Q,!?R'!!
More informationJournal Club WS 2012/13 Stefanie Nickl
Journal Club WS 2012/13 Stefanie Nickl Background Mesenchymal Stem Cells First isolation from bone marrow 30 ys ago Isolation from: spleen, heart, skeletal muscle, synovium, amniotic fluid, dental pulp,
More informationOriginal Article Role of endogenous testosterone in TNF-induced myocardial injury in males
Int J Clin Exp Med 2012;5(2):96-104 www.ijcem.com /ISSN:1940-5901/IJCEM1112002 Original Article Role of endogenous testosterone in TNF-induced myocardial injury in males Meijing Wang, Hongmei Gu, Benjamin
More informationSupplementary Figure 1:
Supplementary Figure 1: (A) Whole aortic cross-sections stained with Hematoxylin and Eosin (H&E), 7 days after porcine-pancreatic-elastase (PPE)-induced AAA compared to untreated, healthy control aortas
More informationPHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker
PACKAGE INSERT Pr PHENTOLAMINE MESYLATE INJECTION SANDOZ STANDARD 5 mg/ ml THERAPEUTIC CLASSIFICATION Alpha-adrenoreceptor Blocker ACTIONS AND CLINICAL PHARMACOLOGY Phentolamine produces an alpha-adrenergic
More information1. Cardiomyocytes and nonmyocyte. 2. Extracellular Matrix 3. Vessels שאלה 1. Pathobiology of Heart Failure Molecular and Cellular Mechanism
Pathobiology of Heart Failure Molecular and Cellular Mechanism Jonathan Leor Neufeld Cardiac Research Institute Tel-Aviv University Sheba Medical Center, Tel-Hashomer שאלה 1 התא הנפוץ ביותר (75%~) בלב
More informationNeuroprotective properties of GLP-1 - a brief overview. Michael Gejl Jensen, MD Dept. Of Pharmacology, AU
Neuroprotective properties of GLP-1 - a brief overview Michael Gejl Jensen, MD Dept. Of Pharmacology, AU mg@farm.au.dk Agenda Glucagon-like peptide (GLP-1) GLP-1 and neuronal activity GLP-1 in disease-specific
More informationList of publications Curriculum Vitae Acknowledgements
List of publications Curriculum Vitae Acknowledgements List of publications 153 LIST OF PUBLICATIONS 1. Van der Bogt KE, Sheik AY, Schrepfer S, Hoyt G, Cao F, Ransohoff K, Swijnenburg RJ, Pearl JI, Lee
More informationKlotho: renal and extra-renal effects
Klotho: renal and extra-renal effects Juan F. Navarro-González, MD, PhD, FASN Nephrology Service and Research Division University Hospital Nuestra Señora de Candalaria Santa Cruz de Tenerife. Spain Klotho:
More informationOriginal Article. Introduction
Original Article The Effects of Na Movement on Surgical Myocardial Protection: The Role of the Na + -H + Exchange System and Na-Channel in the Development of Ischemia and Reperfusion Injury Ke-Xiang Liu,
More informationImpact factor: Reporter:4A1H0019 Chen Zi Hao 4A1H0023 Huang Wan ting 4A1H0039 Sue Yi Zhu 4A1H0070 Lin Guan cheng 4A1H0077 Chen Bo xuan
Curcumin Protects Neonatal Rat Cardiomyocytes against High Glucose-Induced Apoptosis via PI3K/Akt Signalling Pathway Wei Yu,1,2 Wenliang Zha,1 Zhiqiang Ke,1 Qing Min,2 Cairong Li,1 Huirong Sun,3 and Chao
More information2. MATERIALS AND METHODS
2. MATERIALS AND METHODS 2.1 Materials [ 3 H]-Digoxin (37Ci/mmol) was purchased from Perkin-Elmer Life Sciences Inc. (Boston, USA) and [U- 14 C]-Sucrose (660mCi/mmol) was purchased from Amersham Bioscience
More informationGamma-aminobutyric acid (GABA) treatment blocks inflammatory pathways and promotes survival and proliferation of pancreatic beta cells
Gamma-aminobutyric acid (GABA) treatment blocks inflammatory pathways and promotes survival and proliferation of pancreatic beta cells Gérald J. Prud homme, MD, FRCPC Keenan Research Centre for Biomedical
More informationProtocol. Progenitor Cell Therapy for the Treatment of Damaged Myocardium due to Ischemia
(20218) Medical Benefit Effective Date: 01/01/11 Next Review Date: 07/18 Preauthorization No Review Dates: 09/10, 07/11, 07/12, 07/13, 07/14, 07/15, 07/16, 07/17 This protocol considers this test or procedure
More informationAdenosine stimulates the recruitment of endothelial progenitor cells to the ischemic heart
Adenosine stimulates the recruitment of endothelial progenitor cells to the ischemic heart Involvement of the microrna-150-cxcr4-sdf-1α pathway Emeline Goretti, MSc No conflict of interest Endothelial
More informationIn vitro functional study of Cardiomyocyte
In vitro functional study of Cardiomyocyte Gwang Hyeon Eom Department of Pharmacology and Medical Research Center for Gene Regulation Chonnam National University Medical School, Gwangju, South Korea Heart
More informationReactive oxygen species: Importance for ischemia/reperfusion (injury)
Physiologisches Institut Reactive oxygen species: Importance for ischemia/reperfusion (injury) Prof. Dr. Rainer Schulz Reactive oxygen species (ROS) in ischemia/reperfusion injury (IRI) ROS GOOD: Endogenous
More informationCardiac Gene Therapy: Beyond the Mouse. David M Kaye Heart Failure Research Group Baker IDI, Melbourne, AUSTRALIA
Cardiac Gene Therapy: Beyond the Mouse David M Kaye Heart Failure Research Group Baker IDI, Melbourne, AUSTRALIA Presenter Disclosure Information FINANCIAL DISCLOSURE: Equity: Osprey Medical Grants/Research
More informationIn Vivo Animal Models of Heart Disease. Why Animal Models of Disease? Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison
In Vivo Animal Models of Heart Disease Timothy A Hacker, PhD Department of Medicine University of Wisconsin-Madison Why Animal Models of Disease? Heart Failure (HF) Leading cause of morbidity and mortality
More informationCardiomyocyte progenitor cell-derived exosomes stimulate migration of endothelial cells
Translational Cardiology Most Recent Points of View J. Cell. Mol. Med. Vol 14, No 5, 2010 pp. 1064-1070 Guest Editor: P. Doevendans Cardiomyocyte progenitor cell-derived exosomes stimulate migration of
More informationEndothelial PGC 1 - α 1 mediates vascular dysfunction in diabetes
Endothelial PGC-1α mediates vascular dysfunction in diabetes Reporter: Yaqi Zhou Date: 04/14/2014 Outline I. Introduction II. Research route & Results III. Summary Diabetes the Epidemic of the 21st Century
More informationPRP Basic Science. Platelets. Definition of PRP 10/4/2011. Questions that this talk aims to answer
PRP Basic Science Peter J. Moley, MD Hospital for Special Surgery October 5, 2011 Questions that this talk aims to answer 1. What is PRP? 2. What blood components are NOT in PRP? 3. What are the active
More informationMechanics of Cath Lab Support Devices
Mechanics of Cath Lab Support Devices Issam D. Moussa, MD Professor of Medicine Mayo Clinic College of Medicine Chair, Division of Cardiovascular Diseases Mayo Clinic Jacksonville, Florida DISCLOSURE Presenter:
More informationTransplanted Donor Cells Rescue Contra-Lateral Chemo-ablated Muscle Bed
Only 25% of Nuclei are of Donor Origin! R + BCNU DONOR (i.m.) or MGMTP140K WT L + BCNU SALINE (i.m.) O6BG (i.p.) Transplanted Donor Cells Rescue Contra-Lateral Chemo-ablated Muscle Bed Transplanted Donor
More informationRecovery of Myocardial Infarction via Unique Modulation of the Cardiac Microenvironment
2016 춘계심혈관통합학술대회, 경주 Recovery of Myocardial Infarction via Unique Modulation of the Cardiac Microenvironment Youngkeun Ahn, MD, PhD Department of Cardiology, Cardiovascular Center Chonnam National University
More informationBL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES. Overview and Mechanism of Action Dr.
BL-8040: BEST-IN-CLASS CXCR4 ANTAGONIST FOR TREATMENT OF ONCOLOGICAL MALIGNANCIES Overview and Mechanism of Action Dr. Leah Klapper, CSO 88 BL-8040: Novel CXCR4 Antagonist For Hematological Cancers Indications:
More informationIncreased Myocardial Tumor Necrosis Factor- in a Crystalloid-Perfused Model of Cardiac Ischemia- Reperfusion Injury
Increased Myocardial Tumor Necrosis Factor- in a Crystalloid-Perfused Model of Cardiac Ischemia- Reperfusion Injury Daniel R. Meldrum, MD, Joseph C. Cleveland, Jr, MD, Brian S. Cain, MD, Xianzhong Meng,
More informationFull Record.
第 1 頁, 共 2 頁 Full Record Record 1 of 6 (Set #2) Title: Insulin-like growth factor-1 mediates stretch-induced upregulation of myostatin expression in neonatal rat cardiomyocytes Author(s): Shyu KG, Ko WH,
More informationDOWNLOAD PDF CARDIAC REMODELING AND CELL DEATH IN HEART FAILURE
Chapter 1 : The fibrosis-cell death axis in heart failure Remodeling may be defined as changes in the morphology, structure, and function of the heart related to alterations in loading conditions and/or
More informationProduction of Exosomes in a Hollow Fiber Bioreactor
Production of Exosomes in a Hollow Fiber Bioreactor John J S Cadwell, President and CEO, FiberCell Systems Inc INTRODUCTION Exosomes are small lipid membrane vesicles (80-120 nm) of endocytic origin generated
More informationNabeel R. Obeid Mentors: Erin A. Booth and Dr. Benedict R. Lucchesi
Cardioprotective Action of Selective Estrogen-receptor Agonists against Myocardial Ischemia and Reperfusion Injury Nabeel R. Obeid Mentors: Erin A. Booth and Dr. Benedict R. Lucchesi Abstract Cell death
More informationNumerous studies have examined the signaling pathways
Targeted Inactivation of Cystic Fibrosis Transmembrane Conductance Regulator Chloride Channel Gene Prevents Ischemic Preconditioning in Isolated Mouse Heart Hong Chen, MD, PhD*; Luis L. Liu, MD, MSc*;
More informationCell implantation after myocardial infarction: a 10 years experience from the ICREC laboratory
Cell implantation after myocardial infarction: a 10 years experience from the ICREC laboratory BANFF-SCT Joint Scientific Meeting 2017 Barcelona, 29 th March Santi Roura, PhD Grup ICREC IGTP HuGTiP (Badalona)
More informationSUPPLEMENTARY INFORMATION
doi:10.1038/nature10188 Supplementary Figure 1. Embryonic epicardial genes are down-regulated from midgestation stages and barely detectable post-natally. Real time qrt-pcr revealed a significant down-regulation
More informationulcer healing role 118 Bicarbonate, prostaglandins in duodenal cytoprotection 235, 236
Subject Index Actin cellular forms 48, 49 epidermal growth factor, cytoskeletal change induction in mucosal repair 22, 23 wound repair 64, 65 polyamine effects on cytoskeleton 49 51 S-Adenosylmethionine
More informationHDAC Inhibition for Prevention of Fibrosis Following Sepsisinduced
HDAC Inhibition for Prevention of Fibrosis Following Sepsisinduced AKI John A. Kellum, MD, MCCM Professor of Critical Care Medicine, Medicine, Bioengineering and Clinical & Translational Science Vice Chair
More informationSupporting Information
Supporting Information Muraski et al. 10.1073/pnas.0709135105 SI Text Generation of Transgenic Animals. Pim-WT and Pim-DN cdnas were subcloned NheI/SmaI from pegfp-c1 Pim-1 and pegfp-c1 Pim-DN plasmids
More informationSystemic inflammation after myocardial infarction
Zurich Open Repository and Archive University of Zurich Main Library Strickhofstrasse 39 CH-8057 Zurich www.zora.uzh.ch Year: 2013 Systemic inflammation after myocardial infarction Rudiger, Alain DOI:
More informationThe survival of myocardial tissue subjected to ischemia
Basic Science Reports Hearts From Rodents Exposed to Intermittent Hypoxia or Erythropoietin Are Protected Against Ischemia-Reperfusion Injury Zheqing Cai, PhD*; Dominador J. Manalo, PhD*; Guo Wei, MD,
More informationFOCUS ON CARDIOVASCULAR DISEASE
The Consequences of Vitamin D Deficiency: FOCUS ON CARDIOVASCULAR DISEASE Vitamin D deficiency is a global health problem. With all the medical advances of the century, vitamin D deficiency is still epidemic.
More informationThis student paper was written as an assignment in the graduate course
77:222 Spring 2005 Free Radicals in Biology and Medicine Page 0 This student paper was written as an assignment in the graduate course Free Radicals in Biology and Medicine (77:222, Spring 2005) offered
More informationBuffering a Permissive Hypercapnia The Evidence
Buffering a Permissive Hypercapnia The Evidence John Laffey Department of Anesthesia, St Michael s Hospital, University of Toronto, CANADA Disclosures Funding European Research Council [FP-7] Health Research
More informationRelaxation responses of aortic rings from salt-loaded high calcium fed rats to potassium chloride, calcium chloride and magnesium sulphate
Pathophysiology 4 (1998) 275 280 Relaxation responses of aortic rings from salt-loaded high calcium fed rats to potassium chloride, calcium chloride and magnesium sulphate B.J. Adegunloye, O.A. Sofola
More informationENGINEERING THREE DIMENSIONAL CARDIOSPHERES FROM PLURIPOTENT STEM CELLS
ENGINEERING THREE DIMENSIONAL CARDIOSPHERES FROM PLURIPOTENT STEM CELLS A Thesis Presented to The Academic Faculty by Nicole Votaw In Partial Fulfillment of the Requirements for the Degree B.S. in Biomedical
More informationPostn MCM Smad2 fl/fl Postn MCM Smad3 fl/fl Postn MCM Smad2/3 fl/fl. Postn MCM. Tgfbr1/2 fl/fl TAC
A Smad2 fl/fl Smad3 fl/fl Smad2/3 fl/fl Tgfbr1/2 fl/fl 1. mm B Tcf21 MCM Tcf21 MCM Smad3 fl/fl Tcf21 MCM Smad2/3 fl/fl Tcf21 MCM Tgfbr1/2 fl/fl αmhc MCM C 1. mm 1. mm D Smad2 fl/fl Smad3 fl/fl Smad2/3
More informationTrauma Resuscitation: more than just blood products
Trauma Resuscitation: more than just blood products Benjamin T. Houseman, MD, PhD Assistant Professor in Residence Department of Anesthesia University of California San Francisco Traumatic injury Leading
More informationNeue Wirkungsmechanismen von Transfusionsplasma
Neue Wirkungsmechanismen von Transfusionsplasma Lorenzo ALBERIO Médecin chef Hématologie générale et Hémostase Service et Laboratoire centrale d Hématologie CHUV, Lausanne Trauma patient Bleeding Thrombosis
More informationNo option-patients : Is angiogenesis with gene or cell therapy still an option?
No option-patients : Is angiogenesis with gene or cell therapy still an option? Professor Sigrid Nikol Clinical and Interventional Angiology Asklepios-Klinik St. Georg Hamburg, Germany Angiogenic gene
More informationProtection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein
Protection against doxorubicin-induced myocardial dysfunction in mice by cardiac-specific expression of carboxyl terminus of hsp70-interacting protein Lei Wang 1, Tian-Peng Zhang 1, Yuan Zhang 2, Hai-Lian
More informationMasashi Tanaka, Tanaka M Tanaka M Tanaka M Tanaka M Tanaka M
2010 1 1996 1996 2000 2002 2004 2005 2007 2009 2004 1996 2004 2007 2 2007 United States Patent Application Serial No. 11/271,285 for Methods and Compositions for Reducing Injury to a Transplanted Organ
More informationSubject Index. neuronal survival promotion by insulinlike growth factor-i , 162 regulatory proteins 148, 162
Subject Index Acid-labile subunit (ALS) evaluation 84 function 84 growth hormone activity marker 91 growth hormone insensitivity levels 102, 104 Alzheimer s disease, insulin-like growth factor-i neuroprotection
More informationCardiovascular Disease in CKD. Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center
Cardiovascular Disease in CKD Parham Eftekhari, D.O., M.Sc. Assistant Clinical Professor Medicine NSUCOM / Broward General Medical Center Objectives Describe prevalence for cardiovascular disease in CKD
More informationSupplemental Experimental Procedures
Cell Stem Cell, Volume 2 Supplemental Data A Temporal Switch from Notch to Wnt Signaling in Muscle Stem Cells Is Necessary for Normal Adult Myogenesis Andrew S. Brack, Irina M. Conboy, Michael J. Conboy,
More informationSupplementary fig. 1. Crystals induce necroptosis does not involve caspases, TNF receptor or NLRP3. A. Mouse tubular epithelial cells were pretreated
Supplementary fig. 1. Crystals induce necroptosis does not involve caspases, TNF receptor or NLRP3. A. Mouse tubular epithelial cells were pretreated with zvad-fmk (10µM) and exposed to calcium oxalate
More informationInternational Graduate Research Programme in Cardiovascular Science
1 International Graduate Research Programme in Cardiovascular Science This work has been supported by the European Community s Sixth Framework Programme under grant agreement n LSHM-CT-2005-01883 EUGeneHeart.
More informationRECEIVED. W. M. Keck Center for Collaborative Neuroscience 604 Allison Road, D-251 Piscataway, NJ (732)
Principal Investigator: Dongming Sun, W. M. Keck Center for Collaborative Neuroscience 604 Allison Road, D-251 Piscataway, NJ 08854 (732) 445-1832 RECEIVED NJ COMMISSION ON SPINAL CORD RESEARCH The overall
More informationEarly cell death (FGF) B No RunX transcription factor produced Yes No differentiation
Solution Key - Practice Questions Question 1 a) A recent publication has shown that the fat stem cells (FSC) can act as bone stem cells to repair cavities in the skull, when transplanted into immuno-compromised
More informationPhD THESIS FACTORS MODULATING THE THERAPEUTIC POTENTIAL OF ENDOTHELIAL PROGENITOR CELLS FOR NEOVASCULARIZATION OF ISCHEMIC TISSUES
ROMANIAN ACADEMY INSTITUTE OF CELLULAR BIOLOGY AND PATHOLOGY "NICOLAE SIMIONESCU" PhD THESIS FACTORS MODULATING THE THERAPEUTIC POTENTIAL OF ENDOTHELIAL PROGENITOR CELLS FOR NEOVASCULARIZATION OF ISCHEMIC
More information